CZECRIN Research Annual Conference 2021 is over

Events

17 June 2021

CZECRIN Annual Research Conference 2021 is over

Last week, the CZECRIN Annual Research Conference 2021 took place. The originally planned short morning conference finally turned into an all-day event full of interesting topics with interesting guests. Although we could not meet in person, we found something positive in everything and we are glad that even those who would not otherwise be able to listen could listen to this, even if only part of the conference. The program offered a variety of topics in connection with clinical trials, and everyone found somehting interesting.

The conference was opened by a block on disease oriented networks for clinical trials, and 4 existing networks were presented. The block on regulatory science and quality assurance offered a lot of practical information and advice for the smooth running of the study in all ways. There was also a presentation of cooperation with CZECRIN and ECRIN and a presentation of several interesting studies of our own and at other workplaces.

75 guests registered for the event and thanks to the online form of the conference, they were able to join as needed on topics thay were really interested in. In the strongest moments, 59 people joined the conference at the same time. The conference also ran on the YouTube platform, which was watched by a total of 37 viewers at different times. Colleagues from SUKB MUNI helped us with the technical design, for which they deserve a big thank you!

At the end of the conference, a competition quiz was announced, in which the competitors tested their knowledge of the CZECRIN infrastructure, clinical studies and a sense of humor. 3 winners were drawn, to which 3 delicious packages from the Chuť Moravy brand will now go!

We would like to thank all participants, both speakers and listeners, and express their gratitude for their interest in and support for an event such as this, which allows us to further raise awareness of clinical trials and new findings from clinical research.